A rare case of gastroenteritis due to salmonella enterica serovar Infantis in South India
Abstract
Salmonella enterica serovar Infantis is an emerging non-typhoidal Salmonella (NTS) serovar increasingly associated with foodborne gastroenteritis. Human infections caused by this serovar remain underreported in India. We report a case of acute gastroenteritis caused by Salmonella enterica serovar Infantis in a 53-year-old male from South India. The patient presented with acute-onset watery diarrhoea for six days associated with intermittent fever and recent outside food consumption. Stool culture yielded non-lactose fermenting colonies identified by automated identification using the VITEK-2 Compact system as Salmonella group, which was subsequently confirmed as Salmonella enterica serovar Infantis by the National Institute for Research in Bacterial Infections, Kolkata, India. Antimicrobial susceptibility testing revealed susceptibility to ceftriaxone, cefepime, carbapenems, ciprofloxacin, and trimethoprim/sulfamethoxazole, while resistance to aminoglycosides and cefuroxime-axetil was observed. The patient improved clinically with ceftriaxone therapy and supportive management. This case highlights the emerging clinical importance of S. Infantis in India and underscores the necessity of routine serotyping, antimicrobial susceptibility testing, and strengthened surveillance to monitor evolving resistance patterns and public health risks associated with NTS infections.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.